If you want to get past a lot of the hype around generative AI, here’s a trick: Get a bunch of really, really smart folks who have been spending most of the last few years wrangling with it. The consultants and AI CEOs in the room all expressed some frustration that their clients and customers invariably looked at generative AI primarily for productivity and cost cutting. Most agreed that “productivity and cost cutting” were among the least interesting things you could do with generative AI. Chat, they reminded was/is only one way of engaging with generative AI, but its ease of use and its accessibility has already narrowed executive thinking. No matter what you’re doing with generative AI, from drug discovery to marketing copy, you have to review what it is doing very, very closely, and likely will for a lot longer than most experts are now letting on.

Source: New York Times November 07, 2024 14:28 UTC